Doufas A G, Mastorakos G, Chatziioannou S, Tseleni-Balafouta S, Piperingos G, Boukis M A, Mantzos E, Caraiskos C S, Mantzos J, Alevizaki M, Koutras D A
Endocrine Unit, Evgenidion Hospital, Athens University, Athens, Greece.
Eur J Endocrinol. 1999 Jun;140(6):505-11. doi: 10.1530/eje.0.1400505.
Endemic non-toxic goiter (NTG) in Greece has been attributed primarily to iodine deficiency. Thirty years ago about 60% of the prepubertal boys and girls examined in endemic goiter regions presented with NTG and among them thyroid autoimmunity was rarely detected. Although iodine supplementation has corrected this deficiency during the past 30 years, new cases of NTG still appear. To evaluate the prevalence and type of NTG and the effect of iodine supplementation on them in Greece at present, we performed two cross-sectional clinical studies and a retrospective pathology one: (i) thyroid gland volume and urinary iodine excretion (UIE) were assessed in a representative sample of 1213 schoolchildren from previously endemic and non-endemic regions; (ii) serum thyroxine, tri-iodothyronine, TSH, thyroid autoantibodies (AAB) (anti-thyroid peroxidase and anti-thyroglobulin antibodies) and UIE (in 60 patients) were measured in 300 consecutive patients with NTG from Athens and Heraklion; and (iii) we compared the prevalence of autoimmunity among fine needle aspiration smears of benign thyroid pathologies performed by the same pathologist between 1985 and 1986 (975 cases) and between 1994 and 1995 (2702 cases). We found that 12. 5% of the schoolchildren examined in regions with a previous history of endemic goiter had NTG, whereas this percentage was only 1.7% in areas without such a history. In Athens (61.6%) and Heraklion (58. 5%) a substantial number of NTG patients were AAB positive and biochemically hypothyroid. UIE in Athens did not differ between patients with autoimmune goiter (ATG) and simple goiter. The prevalence of autoimmune stigmata in pathology smears has increased from 5.94% (years 1985-1986) to 13.91% (years 1994-1995) (P<0.05). We conclude that: (i) the persistence of endemic goiter in regional foci despite iodine deficiency correction suggests a possible role for a naturally occurring goitrogen; (ii) ATG is the predominant form of NTG in Greece nowadays; and (iii) the five-fold decrease in the prevalence of NTG during the past 30 years followed by the increase of ATG may support the relative character of the latter.
希腊的地方性非毒性甲状腺肿(NTG)主要归因于碘缺乏。30年前,在地方性甲状腺肿地区接受检查的青春期前男孩和女孩中,约60%患有NTG,其中很少检测到甲状腺自身免疫性疾病。尽管在过去30年中补充碘已纠正了这种缺乏,但NTG的新病例仍有出现。为了评估目前希腊NTG的患病率和类型以及补碘对其的影响,我们进行了两项横断面临床研究和一项回顾性病理学研究:(i)在来自以前的地方性和非地方性地区的1213名学童的代表性样本中评估甲状腺体积和尿碘排泄(UIE);(ii)在来自雅典和伊拉克利翁的300例连续NTG患者中测量血清甲状腺素、三碘甲状腺原氨酸、促甲状腺激素、甲状腺自身抗体(AAB)(抗甲状腺过氧化物酶和抗甲状腺球蛋白抗体)和UIE(60例患者);(iii)我们比较了同一位病理学家在1985年至1986年(975例)和1994年至1995年(2702例)期间进行的良性甲状腺病变细针穿刺涂片之间自身免疫性疾病的患病率。我们发现,在以前有地方性甲状腺肿病史的地区接受检查的学童中,12.5%患有NTG,而在没有这种病史的地区,这一比例仅为1.7%。在雅典(61.6%)和伊拉克利翁(58.5%),大量NTG患者AAB呈阳性且生化检查为甲状腺功能减退。雅典自身免疫性甲状腺肿(ATG)患者和单纯性甲状腺肿患者的UIE无差异。病理学涂片上自身免疫性特征的患病率已从5.94%(1985 - 1986年)增至13.91%(1994 - 1995年)(P<0.05)。我们得出结论:(i)尽管碘缺乏得到纠正,但地方性甲状腺肿在局部病灶持续存在,这表明天然存在的致甲状腺肿物质可能起作用;(ii)如今在希腊,ATG是NTG的主要形式;(iii)在过去30年中NTG患病率下降了五倍,随后ATG患病率上升,这可能支持了后者的相对性。